Monopar Therapeutics shares technical analysis: Upward price move faces $72.45 resistance

Monopar Therapeutics shares technical analysis: Upward price move faces $72.45 resistance
Monopar Therapeutics jumps 3.59% today

Monopar Therapeutics (MNPR) stock is trading at $71.92, up 3.59% for the day. The price sits above its short-term averages but remains below key medium- and long-term averages, marking a session of high volatility near the daily highs.

MNPR price prediction
24H -1.09%
$70.4825
48H -2.64%
$69.38
7D -3.26%
$68.9375
1M 1.76%
$72.5125
3M -20.3%
$56.7907
6M -32.9%
$47.8133
12M -5.85%
$67.0888
Current price: $71.26 -0.9900 1.37%
Real-time Data 13:42
Daily range 70.6400 Arrow from to Icon 72.3200
Weekly range 67.2200 Arrow from to Icon 74.9100
Loading...

Highlights

  • MNPR/USD trades above short-term moving averages but faces resistance at key medium-term and long-term levels.
  • Technical indicators show weak momentum with most signals on sell or neutral, except intraday overbought conditions.
  • Expected price range for the coming days is $68.2886 to $75.5514, with a 62% probability of a downward move.

Short-term divergence as resistance holds and indicators stay bearish

On the technical front, MNPR is trading above its MA-20 at $71.17, while still below the MA-50 at $75.46 and the MA-200 at $76.87. The Ichimoku Kijun on the daily chart is set at $72.45 and currently acts as immediate resistance. On the H1 timeframe, momentum is weak: MACD is at Strong Sell, ADX signals Sell, and RSI reads 42.89 (Sell). Stoch RSI is Overbought, CCI is Neutral, and Bull/Bear Power shows buyers intraday. The Awesome Oscillator is Neutral, highlighting intraday strength versus overall negative momentum signals and resulting in a notable short-term divergence.

Monopar Therapeutics asset chart
Monopar Therapeutics price dynamics. Source: TradingView.

Sideways outlook persists as downside risk exceeds breakout potential

Looking ahead, the expected range for MNPR over the next several days is $68.29 to $75.55, consistent with its typical volatility band relative to current levels. The baseline scenario is for sideways movement within this range. There is a 38% probability of an upward move, while downside risk is more likely at 62%. An upside scenario would require a clear break above $72.45 resistance, while failure to hold above $68.29 would open the door for further declines.

Anton Kharitonov, Traders Union expert, sees Monopar Therapeutics trading with high volatility near daily highs but facing clear resistance at $72.45. He believes technical momentum remains weak, with most intraday signals still negative and the stock trading below key medium- and long-term averages. The analyst's base case is for sideways movement within the $68.29 to $75.55 range, with higher probability for downside risk. "Until MNPR holds above $72.45, I stay defensive and would avoid chasing any upside here."

Earlier, analysts noted that Monopar Therapeutics stock was experiencing persistent bearish momentum and elevated downside risk. The current analysis adds nuance by highlighting short-term price strength amid weak overall momentum, with close attention warranted to whether MNPR can break above the immediate $72.45 resistance or risks renewed downside if it fails to hold $68.29 support.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.